Clinical Trials Browser

Phase 4 × Stomach Neoplasms × Irinotecan × Clear all

NCT02366819 2025-06-13

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT01271582 2019-01-29

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Phase 4 Unknown

Gastrointestinal

Neutropenia, Stomach Neoplasms, Colorectal Neoplasms

NCT02401971 2015-03-30

ITAGC

Phase 4 Unknown

Gastrointestinal

Stomach Neoplasms